⚖️ Gilead Tenofovir Cases · no duty to innovate safer drug · SC · Aug. 3📋 Gorobets v. Jaguar Land Rover · Section 998 alternative offers valid · SC · Aug. 6💧 Sonoma County wells · CEQA review required · CA1 · Aug. 4🏛️ Senate Appropriations · 113 bills advance to floor · Aug. 3🔥 AB 1680 Make It FAIR · wildfire insurer overhaul on suspense · Aug. 3🏗️ New Commune DTLA · Builder's Remedy in coastal zone · CA2 · July 30💧 Toy v. San Francisco · Prop 218 validation mandatory · CA1 · July 24⚖️ Gilead Tenofovir Cases · no duty to innovate safer drug · SC · Aug. 3📋 Gorobets v. Jaguar Land Rover · Section 998 alternative offers valid · SC · Aug. 6💧 Sonoma County wells · CEQA review required · CA1 · Aug. 4🏛️ Senate Appropriations · 113 bills advance to floor · Aug. 3🔥 AB 1680 Make It FAIR · wildfire insurer overhaul on suspense · Aug. 3🏗️ New Commune DTLA · Builder's Remedy in coastal zone · CA2 · July 30💧 Toy v. San Francisco · Prop 218 validation mandatory · CA1 · July 24
Sunday Edition · Final sprint · Week of August 3 – August 9, 2026
No duty to innovate
On August 3, the California Supreme Court held in Gilead Tenofovir Cases that pharmaceutical manufacturers cannot be held liable in negligence for failing to commercialize a safer alternative drug when the product plaintiffs actually used is concededly nondefective — rejecting, in a 6–1 decision with four separate opinions, the so-called "duty to innovate."
Justice Groban's majority opinion — joined by Justices Corrigan, Liu, Kruger, and pro tem Justice Desautels — performed a Rowland v. Christian multi-factor analysis and concluded imposing negligence liability for delayed commercialization would discourage pharmaceutical innovation and impose unduly burdensome duties on manufacturers.
Dissent · Justice Evans
1
dissent warns of sweeping immunity
Chief Justice Guerrero concurred separately, arguing a manufacturer that sells a nondefective product owes no duty to develop an alternative. Justice Kruger filed a second concurrence emphasizing the majority assumed only for argument that duty could exist apart from defect. Justice Evans dissented, urging the Legislature to consider whether the immunity the majority grants is proper.
The majority provides pharmaceutical manufacturers with sweeping immunity from negligence liability, no matter how unreasonably they may act or how much serious and avoidable harm they may cause consumers by intentionally delaying the commercialization of safer drugs.
S287946 · filed August 6, 2026 · Justice Corrigan · reverses Court of Appeal
Three days after Gilead, the court issued a unanimous opinion clarifying Code of Civil Procedure section 998: a settlement offer may present alternative sets of terms so long as the offer clearly delineates the choices and at least one alternative is sufficiently certain for accurate valuation at the time the offer is made. The case arose from a lemon-law dispute in which Jaguar Land Rover offered plaintiffs either a lump-sum payment or a category-based buyback formula.
The Court of Appeal had held section 998 prohibits simultaneous offers. Justice Corrigan wrote that "there is nothing inherently uncertain about asking an offeree to evaluate alternative sets of settlement terms before deciding whether to accept either or neither of them" — but emphasized offerors must specify that alternatives are mutually exclusive and independently capable of valuation.
Section 998 now permits structured alternative settlement offers
The Gorobets holding gives litigators new flexibility to craft settlement offers with multiple paths — but the court preserved the offeror's burden to demonstrate validity. Each alternative must be independently valued, clearly labeled, and communicated with instructions for acceptance.
Court of Appeal: two simultaneous section 998 offers inherently invalidSupreme Court: valid when alternatives are clear, mutually exclusive, and at least one is capable of accurate valuation
Assembly bills cleared Senate Appropriations to floor
Sacramento's suspense hearing was not the kill vote — yet
Last week's edition previewed Monday's Senate Appropriations hearing as a fiscal gateway. On August 3, the committee placed 424 measures on its calendar, advanced 113 bills under Senate Rule 28.8 to the Senate floor, and scheduled the actual suspense-file vote for Thursday, August 13 — when hundreds of bills will live or die in a single session.
AB 1680On suspense file · Senate Appropriations · Aug. 3 hearing
Make It FAIR Act targets wildfire insurer of last resort
Commissioner Ricardo Lara and Assemblymember Lisa Calderon's AB 1680 would codify reforms from the Department of Insurance's Report of Examination — finding the California FAIR Plan had not fully implemented 17 critical recommendations across financial condition, governance, and consumer protections. The bill creates civil penalties up to $20,000 per willful violation and expands commissioner authority over coverage limits and clearinghouse programs.
CDI · FAIR PlanStipulation & Order No. 2026-1Effective 2026
Insurance regulation · wildfire season
Commissioner Lara orders expanded FAIR Plan public reporting
As AB 1680 awaits its suspense vote, Commissioner Lara's Stipulation and Order No. 2026-1 already requires the FAIR Plan to report dwelling and commercial policy data broken down by ZIP code, wildfire risk score, and coverage category — reflecting the plan's surge in market share as voluntary insurers retreated from high-risk areas. The order also addresses revolving credit lines to ensure claims-paying capacity after the January 2025 Los Angeles wildfires.
Split appellate ruling orders Sonoma County to complete CEQA review of well ordinance
On August 4, the First District Court of Appeal issued a split decision in Russian Riverkeeper and California Coastkeeper Alliance's challenge to Sonoma County's 2023 groundwater well ordinance — reversing the trial court on Public Trust Doctrine claims but affirming that the county violated CEQA by adopting the ordinance without environmental review.
CountySonoma
Known wells45,000+
First DistrictA168844
CEQAReview required
Associate Justice Tara Desautels wrote that the county's "intent" to protect the environment cannot substitute for the analysis CEQA requires — noting roughly 95 percent of well permit applications would still receive ministerial approval and the county could not quantify water savings from conservation measures.
The appellate court reversed Superior Court Judge Bradford DeMeo's Public Trust ruling, finding Sonoma County gathered information, engaged the public, and fashioned a legislative compromise when amending its well ordinance.
CEQA
Exemption rejected
The same panel upheld CEQA liability, rejecting the county's claim that permit procedures were exempt from review. The case returns to Superior Court for compliance proceedings — now overseen by Judge Jane Gaskell.
Newsom signs ballot access bills as November election nears
Governor Gavin Newsom signed AB 1919 and AB 1923 on August 6 — urgency measures ensuring local ballot measures reach voters in Santa Cruz and Fresno counties before the November 3 general election.
AB 1919 signed
Assemblymember Gail Pellerin's bill authorizes the Santa Cruz Metropolitan Transit District transactions and use tax qualified voter initiative process.
AB 1923 signed
Assemblymember Esmeralda Soria's urgency measure places the Fresno County Transportation Improvement Act — successor to Measure C — on the November ballot after the Board of Supervisors declined to act.
General election
Both counties' transportation funding measures will appear before voters alongside statewide ballot propositions.
First District enforces mandatory validation for water-rate challenges
In a published July 24 opinion, the First District affirmed dismissal of Proposition 218 challenges to San Francisco's 2023 water rates in Toy v. City and County of San Francisco, holding Government Code section 53759 requires covered water and sewer rate challenges to proceed under California's Validation Statutes — and compliance is mandatory and jurisdictional. The decision follows Hiller v. Marin Municipal Water District earlier in 2026; a petition for Supreme Court review is pending in Hiller.
Second District maps Builder's Remedy limits in certified coastal programs
In New Commune DTLA v. City of Redondo Beach, filed July 30, the Second District Division Four upheld Redondo Beach's denial of a 30-unit mixed-use Builder's Remedy project on land designated in the certified local coastal program for public access and coastal recreation only — not residential use. The court distinguished prior cases where residential use was already permitted and technical nonconformities were approved, holding local agencies must make statutory findings supported by a preponderance of the evidence to deny Builder's Remedy projects in the coastal zone.
Dozens of AI bills await August 13 kill-or-survive votes
The Transparency Coalition reported that Senate and Assembly Appropriations committees placed most AI measures on suspense this week, with formal votes scheduled August 13 — including workplace surveillance bills, healthcare AI measures, and SB 867 banning AI companion chatbots in children's toys.
SB 867
AI chatbots in toys
Would prohibit companion chatbots in children's toys. Passed Senate 39–0; on Assembly Appropriations suspense file after Privacy Committee approval.
The kill-or-survive event: both Appropriations committees vote on bills placed on suspense, including AB 1680, SB 867, SB 813, and dozens of AI and housing measures.
Final deadline for Appropriations committees to report bills to the floor under Joint Rule 61(b)(14). After this date, only floor sessions and conference committees may act.